217 related articles for article (PubMed ID: 23727661)
21. Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.
Boyd RS; Jukes-Jones R; Walewska R; Brown D; Dyer MJ; Cain K
Mol Cell Proteomics; 2009 Jul; 8(7):1501-15. PubMed ID: 19346216
[TBL] [Abstract][Full Text] [Related]
22. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
Mollinedo F; Gajate C
J Lipid Res; 2020 May; 61(5):611-635. PubMed ID: 33715811
[TBL] [Abstract][Full Text] [Related]
23. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
24. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
25. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM
Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881
[TBL] [Abstract][Full Text] [Related]
26. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
[TBL] [Abstract][Full Text] [Related]
27. p110α Inhibition Overcomes Stromal Cell-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma.
Guan J; Huang D; Yakimchuk K; Okret S
Mol Cancer Ther; 2018 May; 17(5):1090-1100. PubMed ID: 29483220
[TBL] [Abstract][Full Text] [Related]
28. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway.
Lin MT; Lee RC; Yang PC; Ho FM; Kuo ML
J Biol Chem; 2001 Dec; 276(52):48997-9002. PubMed ID: 11585835
[TBL] [Abstract][Full Text] [Related]
30. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
[TBL] [Abstract][Full Text] [Related]
31. SDF-1α/CXCR4 Signaling in Lipid Rafts Induces Platelet Aggregation via PI3 Kinase-Dependent Akt Phosphorylation.
Ohtsuka H; Iguchi T; Hayashi M; Kaneda M; Iida K; Shimonaka M; Hara T; Arai M; Koike Y; Yamamoto N; Kasahara K
PLoS One; 2017; 12(1):e0169609. PubMed ID: 28072855
[TBL] [Abstract][Full Text] [Related]
32. 8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.
Dennison JB; Shanmugam M; Ayres ML; Qian J; Krett NL; Medeiros LJ; Neelapu SS; Rosen ST; Gandhi V
Blood; 2010 Dec; 116(25):5622-30. PubMed ID: 20844237
[TBL] [Abstract][Full Text] [Related]
33. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Reis-Sobreiro M; Gajate C; Mollinedo F
Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642
[TBL] [Abstract][Full Text] [Related]
34. Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt.
Schulze-Bergkamen H; Brenner D; Krueger A; Suess D; Fas SC; Frey CR; Dax A; Zink D; Büchler P; Müller M; Krammer PH
Hepatology; 2004 Mar; 39(3):645-54. PubMed ID: 14999683
[TBL] [Abstract][Full Text] [Related]
35. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
36. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
Guenther MK; Graab U; Fulda S
Cancer Lett; 2013 Sep; 337(2):200-9. PubMed ID: 23684925
[TBL] [Abstract][Full Text] [Related]
37. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
38. Enforced C-Src Activation Causes Compartmental Dysregulation of PI3K and PTEN Molecules in Lipid Rafts of Tongue Squamous Carcinoma Cells by Attenuating Rac1-Akt-GLUT-1-Mediated Sphingolipid Synthesis.
Wu CW; Wang SG; Lee CH; Chan WL; Lin ML; Chen SS
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823607
[TBL] [Abstract][Full Text] [Related]
39. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.
Gajate C; Mollinedo F
Apoptosis; 2015 May; 20(5):584-606. PubMed ID: 25702154
[TBL] [Abstract][Full Text] [Related]
40. Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.
Yu D; Zhang Y; Chen G; Xie Y; Xu Z; Chang S; Hu L; Li B; Bu W; Wang Y; Xiao W; Sun X; Chang G; Gao L; Qiang S; Wu X; Zhu W; Shi J
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):782-792. PubMed ID: 29961897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
